BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
Mirna garners $5 million state grant
-
IMUC signs option agreement with MD Anderson Cancer Center
-
UTSA adopts Click Commerce’s research, compliance software
-
Sole Finalist Named for UTPA President Position
-
Collaboration creates 250 jobs in Richardson
-
Gophers to Play Texas at TCF Bank Stadium in 2015
-
Tech research at UT in line for $2M in funding
-
University of Texas at Dallas receives 16 gifts worth more than $16.8M
-
RF Code Announces First Ever Wire-Free Liquid Detection Sensor
-
In the race to turn back the biological clock, consumers are reaching for an unproven...
-
TerraTherm, Inc.: TerraTherm Royalty Payments to The University of Texas at Austin Top $1 Million...
News & Analysis
Filter by
healthcare and university of texas and vaccine - All News and Analysis
Homeland security contracts.(Department of Homeland Security signs University of Texas, BBN Technologies and Applied Research Associates Inc.)(Brief Article)
- 2005-11-01
Homeland Security Contracts AWARDEE AMOUNT PURPOSE University of Texas $6.4 million Five-year research grant to study...
Department of Health and Human Services.(Grants & Contracts)
- 2005-09-20
DEPARTMENT OF HEALTH AND HUMAN SERVICES has awarded the University of Texas at San Antonio a five-year, $6.4 million grant to develop vaccines against tularemia, a potential bioterror agent. Contact: Chris Rodriguez, public affairs specialist, UTSA, (210) 458-4550, http://utsa.edu/today/2005/09/tularemia.cfm.
Clinical trial begins at UT Southwestern to test ricin vaccine safety, efficacy.(University of Texas, RiVax)(Brief Article)
- 2004-12-14
The Food and Drug Administration has approved a human clinical trial of RiVax, a potential vaccine developed at the University of Texas UT Southwestern Medical Center to protect against the deadly toxin ricin. Dr. Ellen Vitetta and her research team developed RiVax as an...
DOR BioPharma Executes Option for Non-Toxic Ricin Vaccine Technology From University of Texas Southwestern Medical Center
- 2003-01-07
Business Editors/Medical Writers LAKE FOREST, Ill.--BUSINESS WIRE--Jan. 7, 2003 Complements MicrovaxTM Ricin Vaccine Initiative Announced by DOR on Sept. 11, 2002 DOR BioPharma Inc. (AMEX:DOR) ("DOR") announced today that it has executed an exclusive option with the University of Texas Southwestern Medical Center UT Southwestern in...
- 1
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
Presented by American Express